Wednesday, Feb 19 2020 | Time 18:09 Hrs(IST)
image
  • Cabinet approves elevation of BISAG as BISAG(N) under MEITY
  • CCEA approves upward revision of interest subvention under DIDF
  • UP govt has no project pending on river linking: Minister
  • Top commander among 3 militants killed in Tral encounter
  • MP CM bows to Shivaji
  • Tapas Pal's death: Mamata becomes 'explosive,' accuses BJP of 'revenge'
  • Javadekar unveils India 2020 book
  • Twenty-three militants killed in 10 operations, 40 OGWs arrested since Jan in J&K: DGP
  • Cabinet approves Swachh Bharat Mission (Grameen) Phase-II
  • Cabinet nod for historic ART Regulation Bill 2020
  • Youth run over by truck in Jalna
  • Periodic breaks helps: Kohli
  • Periodic breaks helps: Kohli
  • Cabinet approves revamping of Pradhan Mantri Fasal Bima Yojana
  • CCEA approves scheme for Formation and Promotion of FPOs
World


Well-prepared laboratories are first line of defence against novel Coronavirus in Europe

Well-prepared laboratories are first line of defence against novel Coronavirus in Europe

Copenhagen, Feb 11 (UNI) Timely detection of a contagious pathogen is vital to controlling its spread.



In response to the emergency of novel coronavirus (2019-nCoV), WHO is working closely with a network of designated laboratories in the WHO European Region and other WHO regions to ensure that every country has the capacity and resources required to quickly test, report and respond to any suspected cases of the disease. In particular, WHO/Europe is facilitating shipment of testing kits, within a month of the virus first being isolated.



Working largely unseen, in the context of routine disease surveillance or in the event of acute disease outbreaks, laboratories are a vital link in the chain of activities required to keep populations safe from diseases.



Recognising this, WHO/Europe and the European Centre for Disease Prevention and Control (ECDC) moved quickly following identification of the novel virus on January 7 last to identify laboratory needs and capacities in the European Region.



WHO/Europe and partners established a roster of 6 international laboratories in the Region to act as regional referral laboratories to provide testing support to laboratories working at country level. These laboratories are located in France, Germany, the Netherlands, the Russian Federation and the United Kingdom.



A network of nationally designated laboratories for testing of 2019-nCoV was also activated, primarily building on the existing laboratory network within the Global Influenza Surveillance and Response System (GISRS).



Thanks to China’s swift release of the full virus sequence, the first protocol for diagnostic testing of samples collected from potentially infected patients and their contacts became available in early January. This enabled 31 countries in the Region to rapidly establish testing capacities.



WHO also commissioned the manufacturing of test kits for global distribution to the designated 2019-nCoV laboratories. WHO/Europe is facilitating a first round of shipment of 192 kits (containing 100 tests each) to 20 laboratories in the Region. Globally, WHO is making 250 000 tests available to 159 laboratories.



Countries with no testing capacity can send their samples to the WHO appointed 2019-nCoV referral laboratories for testing. New 2019-nCoV laboratories are also encouraged to send the first 5 positive and the first 10 negative 2019-nCoV samples to their referral laboratories for confirmation of test results.



To ensure rapid and free-of-charge shipment of samples, WHO repurposed the Shipping Fund Project established by the GISRS. In addition, WHO and partners are developing an external quality assurance programme for national 2019-nCoV laboratories.



This rapid expansion of testing capacity is increasing preparedness in each country to reduce the risk of infection and spread of the virus. Available data on the spread of the virus changes daily. The vast majority of patients around the world is in China, and China’s strategy to contain the outbreak at its epicentre is proving effective, with only a few hundred cases so far in the rest of the world.

This is the European Region’s window of opportunity to prepare in every country for a potential introduction of 2019-nCoV. This includes strengthening capacities to find, test and care for patients; to prevent and control infections; and to communicate risks with the public.

UNI XC-BM NC0651

More News
No trade deal during Trump India visit

No trade deal during Trump India visit

19 Feb 2020 | 4:42 PM

Washington, Feb 19 (UNI) India and the United States won't sign a trade deal during President Donald Trump's February 24-25 visit to New Delhi.

see more..
Coronavirus: 2,004 died in China's Hubei province

Coronavirus: 2,004 died in China's Hubei province

19 Feb 2020 | 8:56 AM

Tokyo, Feb 19 (UNI) As many as 2,004 people have died from the novel coronavirus disease in the Chinese province of Hubei, the provincial health commission said on Wednesday.

see more..
Death toll from deadly coronavirus nears 2000 in China

Death toll from deadly coronavirus nears 2000 in China

18 Feb 2020 | 6:55 PM

Beijing, Feb 18 (UNI) The death toll from China's coronavirus epidemic reached 1,868 on Tuesday, according to the National Health Commission.

see more..
FATF asks Pakistan to tighten laws against terror financing

FATF asks Pakistan to tighten laws against terror financing

18 Feb 2020 | 6:03 PM

Islamabad, Feb 18 (UNI) Terror watchdog, Financial Action Task Force (FATF), has asked Pakistan to enact tougher laws to check terror financing and take strict penal action against individuals involved in it.

see more..
UN Secy Gen visits Kartarpur gurdwara

UN Secy Gen visits Kartarpur gurdwara

18 Feb 2020 | 6:00 PM

Islamabad, Feb 18 (UNI) United Nations Secretary General Antonio Guterres visited Kartarpur Corridor on Tuesday and termed it as a "corridor of hope" and symbol of interfaith harmony.

see more..
image